世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033645

放射線皮膚炎市場規模、シェア、動向分析レポート、予測2023-2030

Grand View Research Inc.

Radiodermatitis Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2023 - 2030

発刊日 2022/11

言語英語

体裁PDF/110ページ

ライセンス/価格110ページ

0000033645

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

放射線皮膚炎の市場規模、シェア 、動向分析レポート:製品別 (外用剤、コルチコステロイド、親水性クリーム、抗生物質、ドレッシング、ハイドロゲル & ハイドロコロイド)、流通経路別、地域別、およびセグメント予測、2023〜 2030

レポートの概要
世界の放射線皮膚炎の市場規模は、2022 年に 4 億 1,260 万ドルと推定され、2023 年から 2030 年までに3.9%のCAGR で拡大が予想されます。市場をけん引する主な要因は、放射線療法の副作用として放射線皮膚炎を発症する患者数の増加です。放射線皮膚炎のの悪影響を食い止める必要があるため、治療薬の必要性がこれまで以上に緊急度を増しています。紅斑、乾性落屑、湿性落屑などの放射線皮膚炎は、放射線療法を受けるがん患者の 95% に影響を及ぼします。また、乳癌の放射線療法を受けている患者の 85 〜 95% がさまざまな重症度の放射線皮膚炎を経験していると推定されています。

レポート詳細

目次

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region-wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Region-Based Segment Share Calculation
1.3 List of Secondary Sources

Chapter 2 Executive Summary

Chapter 3 Radiodermatitis Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & Growth Prospect Mapping
3.5 Radiodermatitis Market - SWOT Analysis, By Factor (Political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
3.7 COVID-19 Impact Analysis

Chapter 4 Radiodermatitis Market: Product Estimates & Trend Analysis
4.1 Radiodermatitis Market: Product Movement Analysis
4.2 Topical
4.2.1 Topical Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.2.2 Corticosteroids
4.2.2.1 Corticosteroids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.2.3 Hydrophilic Creams
4.2.3.1 Hydrophilic Creams Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.2.4 Antibiotics
4.2.4.1 Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.2.5 Others
4.2.5.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.3 Oral
4.3.1 Oral Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4 Dressings
4.4.1 Dressings Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.2 Hydrogel & Hydrocolloid Dressing
4.4.2.1 Hydrogel & Hydrocolloid Dressing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.3?No Sting Barrier Film
4.4.3.1 No Sting Barrier Film Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.4 Honey?Impregnated Gauze
4.4.4.1 Honey Impregnated Gauze Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.5 Silicone?Coated Dressings
4.4.5.1 Silicone Coated Dressings Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4.6 Others
4.4.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Radiodermatitis Market: Distribution Channel Estimates & Trend Analysis
5.1 Radiodermatitis Market: Distribution Channel Movement Analysis
5.2 Hospital Pharmacies
5.2.1 Hospital Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.3 Retail Pharmacies
5.3.1 Retail Pharmacies Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4 Online Pharmacies
5.4.1 Online Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Radiodermatitis Market: Regional Estimates & Trend Analysis, by Product & Distribution Channel
6.1 Radiodermatitis Market Shares By Region, 2022 & 2030
6.2 North America
6.2.1 North America Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.2.2 North America Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.2.3.2 U.S. Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.2.4 Canada
6.2.4.1 Canada Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.2.4.2 Canada Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.3.2 Europe Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.3.3 U.K.
6.3.3.1 U.K. radiodermatitis Market Estimates And Forecasts, 2018 - 2030(USD Million)
6.3.3.2 U.K. Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.3.3.3 U.K. Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.3.4 Germany
6.3.4.1 Germany Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.3.4.2 Germany Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.3.5 France
6.3.5.1 France Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.3.5.2 France Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.3.6 Italy
6.3.6.1 Italy Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.3.6.2 Italy Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.3.7 Spain
6.3.7.1 Spain Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.3.7.2 Spain Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.3.8 Denmark
6.3.8.1 Denmark Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.3.8.2 Denmark Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.3.9 Sweden
6.3.9.1 Sweden Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.3.9.2 Sweden Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.3.10 Norway
6.3.10.1 Norway Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.3.10.2 Norway Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.4.2 Asia Pacific Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.4.3 Japan
6.4.3.1 Japan Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.4.3.2 Japan Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.4.4 China
6.4.4.1 China Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.4.4.2 China Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.4.5 India
6.4.5.1 India Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.4.5.2 India Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.4.6 Australia
6.4.6.1 Australia Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.4.6.2 Australia Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.4.7 South Korea
6.4.7.1 South Korea Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.4.7.2 South Korea Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.4.8 Thailand
6.4.8.1 Thailand Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.4.8.2 Thailand Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.5.2 Latin America Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.5.3.2 Brazil Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexico Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.5.4.2 Mexico Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.5.5 Argentina
6.5.5.1 Argentina Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.5.5.2 Argentina Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.6.2 MEA Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.6.3.2 South Africa Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.6.4 Saudi Arabia
6.6.4.1 Saudi Arabia Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.6.4.2 Saudi Arabia Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.6.5 UAE
6.6.5.1 UAE Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.6.5.2 UAE Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)
6.6.6 Kuwait
6.6.6.1 Kuwait Radiodermatitis Market, by Product, 2018 - 2030 (USD Million)
6.6.6.2 Kuwait Radiodermatitis Market, by Distribution Channel, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Stratpharma AG
7.3.1.1 Company Overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Smith & Nephew
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Molnlycke Health Care AB
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Derma Sciences Inc.
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic initiatives
7.3.5 ConvaTec Inc.
7.3.5.1 Company Overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.6 BMG Pharma S.R.L.
7.3.6.1 Company Overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Acelity
7.3.7.1 Company Overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 3M
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.9 Alliqua BioMedical
7.3.9.1 Company Overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.4.4 Strategic initiatives

List of Tables
TABLE 1 List of secondary sources
TABLE 2 List of Abbreviations

List of Figures
FIG. 1 Market outlook
FIG. 2 Market segmentation & scope
FIG. 3 Market driver relevance analysis (Current & future impact)
FIG. 4 Market restraint relevance analysis (Current & future impact)
FIG. 5 Penetration & growth prospect mapping
FIG. 6 SWOT Analysis, By Factor (Political & legal, economic and technological)
FIG. 7 Porter’s Five Forces Analysis
FIG. 8 Radiodermatitis market, product outlook: Key takeaways
FIG. 9 Radiodermatitis market: Product movement analysis
FIG. 10 Global topical market, 2018 - 2030 (USD Million)
FIG. 11 Global corticosteroid market, 2018 - 2030 (USD Million)
FIG. 12 Global hydrophilic creams market, 2018 - 2030 (USD Million)
FIG. 13 Global antibiotics market, 2018 - 2030 (USD Million)
FIG. 14 Global others market, 2018 - 2030 (USD Million)
FIG. 15 Global oral market, 2018 - 2030 (USD Million)
FIG. 16 Global dressings market, 2018 - 2030 (USD Million)
FIG. 17 Global hydrogel & hydrocolloid dressing market, 2018 - 2030 (USD Million)
FIG. 18 Global no sting barrier film market, 2018 - 2030 (USD Million)
FIG. 19 Global honey impregnated gauze market, 2018 - 2030 (USD Million)
FIG. 20 Global silicone coated dressings market, 2018 - 2030 (USD Million)
FIG. 21 Global others market, 2018 - 2030 (USD Million)
FIG. 22 Radiodermatitis market, distribution channel outlook: Key takeaways
FIG. 23 Radiodermatitis market: Distribution channel movement analysis
FIG. 24 Global hospital pharmacies market, 2018 - 2030 (USD Million)
FIG. 25 Global retail pharmacies market, 2018 - 2030 (USD Million)
FIG. 26 Global online pharmacies market, 2018 - 2030 (USD Million)
FIG. 27 Regional market place: Key takeaways
FIG. 28 Regional outlook, 2022 & 2030
FIG. 29 U.S. Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 30 Canada radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 31 Germany Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 32 U.K. radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 33 Germany Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 34 France radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 35 Italy Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 36 Spain radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 37 Denmark Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 38 Sweden radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 39 Norway Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 40 China radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 41 Japan Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 42 India radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 43 Australia Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 44 South Korea radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 45 Thailand Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 46 Brazil radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 47 Mexico Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 48 Argentina radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 49 South Africa Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 50 Saudi Arabia radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 51 UAE Radiodermatitis market, 2018 - 2030 (USD Million)
FIG. 52 Kuwait radiodermatitis market, 2018 - 2030 (USD Million)

この商品のレポートナンバー

0000033645

TOP